["{\n\"step_by_step_thinking\": \"The question asks why the patient should not be switched to exenatide. Exenatide is an injectable drug that only needs to be administered once a week. The patient has type 1 diabetes mellitus, which means insulin production by the pancreas is insufficient. This information is not explicitly stated in the given documents, but it can be inferred from the fact that the patient requires insulin therapy and his blood glucose levels have been difficult to control. Exenatide works by suppressing glucagon secretion, which could increase the risk of hypoglycemia if the patient's insulin production is insufficient.\",\n\"answer_choice\": \"B\"\n}"]